Maxime du Merle

Maxime DU MERLE has extensive experience in the field of clinical research. Maxime started their career as a Junior Clinical Research Associate at Kappa Santé in 2008. Maxime then worked as a Clinical Research Associate at CLINACT, Groupe MultiHealth, where they were dedicated to projects for Roche and Novartis. In 2011, they joined IQVIA as a Senior Clinical Research Associate, focusing on projects for Roche. Moving on to EXCELYA in 2014, Maxime took on the role of National Lead Clinical Research Associate, primarily working on studies for AstraZeneca. In 2022, they joined Ividata as the International Lead CRA dedicated to Cerner Enviza. Currently, Maxime is employed by AIXIAL GROUP as the Clinical Monitoring Lead for IPSEN. In this role, they are responsible for overseeing and coordinating clinical activities to ensure the efficient implementation and monitoring of studies.

Maxime Du Merle completed a CRA training course in Clinical Research at ADDS in 2007. Maxime obtained an MSC in Food and Health science from the University of Caen from 2004 to 2005. Prior to that, they earned a BSC and MSC in Biology from the University of Versailles-St Quentin from 2000 to 2004. Maxime began their education by studying medicine at la Pitié Salpetrière, Paris VI from 1998 to 2000.